$Edwards Lifesciences (EW.US)$Revenue has continued to grow ...
$Edwards Lifesciences(EW.US$Revenue has continued to grow over the past 5 years, with an average growth rate of 9.4%. Operating profit also increased continuously for 5 years, with an average growth rate of 12%. Net profit increased in 4 years, with an average growth rate of 21%, in addition to a 21.4% decline in 2020.
2023Q1 revenue increased 8.8%, operating profit decreased 2.4%, and net profit decreased 8.9%.
The current price is $85.3, 35 times the price-earnings ratio, and 35.4 times the price-earnings ratio TTM is not underestimated and unattractive.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
